187 related articles for article (PubMed ID: 32833086)
1. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review.
Carrión-Barberà I; Pros A; Salman-Monte TC; Vílchez-Oya F; Sánchez-Schmidt JM; Pérez-García C; Monfort J
Clin Rheumatol; 2021 May; 40(5):2065-2070. PubMed ID: 32833086
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.
Krusche M; Ruffer N; Kötter I
Rheumatol Int; 2019 Feb; 39(2):337-344. PubMed ID: 30465270
[TBL] [Abstract][Full Text] [Related]
3. A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report.
Boistault M; Lopez Corbeto M; Quartier P; Berbel Arcobé L; Carsi Durall A; Aeschlimann FA
Pediatr Rheumatol Online J; 2021 Dec; 19(1):168. PubMed ID: 34861842
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
Erhardt A; Sagir A; Guillevin L; Neuen-Jacob E; Häussinger D
J Hepatol; 2000 Oct; 33(4):677-83. PubMed ID: 11059878
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection associated with polyarteritis nodosa and microscopic polyangiitis.
Meng Z; Cui W; Arend L; Mikdashi J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34011661
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Kruger M; Böker KH; Zeidler H; Manns MP
J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up.
McMahon BJ; Heyward WL; Templin DW; Clement D; Lanier AP
Hepatology; 1989 Jan; 9(1):97-101. PubMed ID: 2562798
[TBL] [Abstract][Full Text] [Related]
8. Polyarteritis nodosa associated with gastric carcinoma and hepatitis B virus infection.
Yamada T; Miwa H; Ikeda K; Ohta K; Iwazaki R; Miyazaki A; Watanabe S; Hashimoto H; Futagawa S; Sato N
J Clin Gastroenterol; 1997 Oct; 25(3):535-7. PubMed ID: 9412972
[TBL] [Abstract][Full Text] [Related]
9. [Polyarteritis nodosa related to hepatitis b virus infection].
Demolin G; Delwaide J; Van Severen M; Demolin H; Cornet G; Belaiche J
Rev Med Liege; 1999 Dec; 54(12):921-4. PubMed ID: 10686797
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
Lau CF; Hui PK; Chan WM; Fung TT; Tung YM; Loo CK; Yip WC; Lam KM
Eur J Gastroenterol Hepatol; 2002 May; 14(5):563-6. PubMed ID: 11984157
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-related polyarteritis nodosa presenting with multiple lung nodules and cavitary lesions.
Naniwa T; Maeda T; Shimizu S; Ito R
Chest; 2010 Jul; 138(1):195-7. PubMed ID: 20605819
[TBL] [Abstract][Full Text] [Related]
12. [Polyarteritis Nodosa, a vanishing vasculitis since its main cause has been identified].
Frey FJ
Ther Umsch; 2008 May; 65(5):247-51. PubMed ID: 18622927
[TBL] [Abstract][Full Text] [Related]
13. [The changing face of medium-sized vasculitis].
Parada-Turska J; Turska M
Wiad Lek; 2018; 71(1 pt 1):64-72. PubMed ID: 29558354
[TBL] [Abstract][Full Text] [Related]
14. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
Janssen HL; van Zonneveld M; van Nunen AB; Niesters HG; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):801-7. PubMed ID: 15256984
[TBL] [Abstract][Full Text] [Related]
15. Benign cutaneous polyarteritis nodosa. Relationship to systemic polyarteritis nodosa and to hepatitis B infection.
Minkowitz G; Smoller BR; McNutt NS
Arch Dermatol; 1991 Oct; 127(10):1520-3. PubMed ID: 1681787
[TBL] [Abstract][Full Text] [Related]
16. [Polyarteritis nodosa: differential diagnostics and therapy].
Schirmer JH; Holl-Ulrich K; Moosig F
Z Rheumatol; 2014 Dec; 73(10):917-26; quiz 926-7. PubMed ID: 25391370
[TBL] [Abstract][Full Text] [Related]
17. Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L; Horisberger A; Moi L; Karampetsou MP; Comte D
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068989
[TBL] [Abstract][Full Text] [Related]
18. Systemic polyarteritis nodosa following hepatitis B vaccination.
de Carvalho JF; Pereira RM; Shoenfeld Y
Eur J Intern Med; 2008 Dec; 19(8):575-8. PubMed ID: 19046721
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab treatment for polyarteritis nodosa.
Krusche M; Ruffer N; Schneider U; Meyer M; Burmester G; Kötter I
Rheumatology (Oxford); 2020 Oct; 59(10):e63-e65. PubMed ID: 32182367
[No Abstract] [Full Text] [Related]
20. Hepatitis B-associated polyarteritis nodosa and hypertensive encephalopathy.
Balkaran BN; Teelucksingh S; Singh VR
West Indian Med J; 2000 Jun; 49(2):170-1. PubMed ID: 10948860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
